4//SEC Filing
Giffin Brett A. 4
Accession 0000950170-23-066398
CIK 0001492674other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:05 PM ET
Size
6.6 KB
Accession
0000950170-23-066398
Insider Transaction Report
Form 4
Giffin Brett A.
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-11-08+33→ 64 total - Exercise/Conversion
Restricted Stock Units
2023-11-08−33→ 34 total→ Common Stock (33 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On February 26, 2022 the reporting person was granted 100 RSU's that vest in three equal annual installments on November 8, 2022, November 8, 2023, and October 1, 2024.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001892921
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 4:05 PM ET
- Size
- 6.6 KB